Role of Prominent Scientist Divides German Peace Groups

WASHINGTON—Leftist members of the peace movement here have challenged the commitment of renowned physicist Carl Friedrich von Weizsäcker to their cause, sparking a debate over the role of scientists in political issues. Weizsäcker, at 75 an elder statesman in the movement, was a key member of a small team of German scientists who worked unsuccessfully on controlled nuclear fission during World War II. For the past 40 years he has analyzed the dangers of nuclear war. Last fa

Written byDaniel Charles
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—Leftist members of the peace movement here have challenged the commitment of renowned physicist Carl Friedrich von Weizsäcker to their cause, sparking a debate over the role of scientists in political issues.

Weizsäcker, at 75 an elder statesman in the movement, was a key member of a small team of German scientists who worked unsuccessfully on controlled nuclear fission during World War II. For the past 40 years he has analyzed the dangers of nuclear war.

Last fall, however, a magazine article by Alfred Mechtersheimer, a member of the West German parliament from the leftist Green Party, accused the elderly scientist of being an ivory-tower intellectual. The author, a former researcher in an institute headed by Weizsacker, said the physicist had been unwilling or unable to transform his analysis into opposition to government policy.

Weizsäcker has declined to comment publicly on the controversy. But Mechtersheimer, in a recent phone interview, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies